Ampio Pharmaceuticals Depreciation & Amortization 2011-2026 | AMPE

Annual Depreciation & Amortization Ampio Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
122 K	1.05 M	1.09 M	1.18 M	1.27 M	1.28 M	1.21 M	1.21 M	825 K	341 K	138 K	62.4 K	42.6 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.28 M	42.6 K	756 K

Quarterly Depreciation & Amortization Ampio Pharmaceuticals

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
122 K	122 K	122 K	-	865 K	518 K	262 K	-	831 K	568 K	294 K	-	885 K	591 K	295 K	-	975 K	736 K	365 K	-	968 K	621 K	301 K	-	911 K	607 K	304 K	-	917 K	611 K	306 K	-	816 K	462 K	231 K	-	210 K	83.1 K	41.2 K	-	97.3 K	57.8 K	18.5 K	-	46.8 K	31.2 K	15.6 K	-	27 K	11.4 K	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
975 K	11.4 K	401 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	2.1 M	-	-	$ 2.18 B	USA
Alpine Immune Sciences ALPN	576 K	-	-	$ 2.17 B	USA
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
CRISPR Therapeutics AG CRSP	19.5 M	$ 49.8	-0.86 %	$ 4.48 B	Schweiz
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	3.38 M	$ 31.27	4.37 %	$ 2.08 B	USA
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	1.74 M	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	58.8 M	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	5.37 M	$ 14.72	-	$ 211 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Enlivex Therapeutics Ltd. ENLV	332 K	$ 0.67	-6.8 %	$ 30.6 M	Israel
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 2.84	-0.35 %	$ 4.68 M	Israel
Forte Biosciences FBRX	64 K	$ 17.56	0.92 %	$ 227 M	USA
Esperion Therapeutics ESPR	105 K	$ 3.15	-	$ 655 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	7.72 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 24.38	-0.85 %	$ 3.1 B	USA